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Abstract: Epidermolysis Bullosa is a genetic disorder that affects mainly the skin, however, all others systems are
influenced. The nutritional care of children and adolescents with Epidermolysis Bullosa is a key treatment strat-
egy, since the energy needs are increased due to the disease’s metabolism, burdening the immune system and
cicatrization process, symptoms caused by the disease hinder the intake and adequate absorption of nutrients,
which may result in inadequate growth and development. Because this is a rare disease, there are few profession-
als who know the characteristics of both the clinical evolution and nutritional and dietary treatments. This liter-
ature review discusses the latest knowledge on energy and specific nutrient requirements to the dietary treatment
and monitoring of children and adolescents with Epidermolysis Bullosa.
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INTRODUCTION
The term Epidermolysis Bullosa (EB) was intro-
duced in 1886 and refers to a group of inherited bul-
lous diseases characterized by the appearance of blis-
ters as a result of minimal mechanical trauma, caused
by mutations in genes that encode any of the structur-
al components of keratinocytes and the dermoepider-
mal junction.1,2 Mutations cause changes in proteins
that are responsible for adhesion defects between
cutaneous structures, leading to the formation of blis-
ters.3 Currently EB is classified into four main groups
according to the location of the skin separation, i.e.,
they are differentiated by the ultrastructural level at
which blisters develop. Thus, they can be grouped as:
epidermolytic types encompassing epidermolysis bul-
losa simplex (EBS) with intraepidermal separation
(involved proteins: keratin 5 and 14) and junctional
epidermolysis bullosa (JEB), in which separation
occurs inside the lamina lucida (involved proteins:
laminin 332, type XVII collagen and integrin α6β4);
dermolytic type such as dystrophic epidermolysis
bullosa (DEB) with cleavage inside the lamina densa
(involved protein: type VII collagen) and a mixed type
that refers to Kindler syndrome, in which separation
occurs in the laminas lucida and densa (proteins
involved: Type VII collagen and Kindlin I).2
EB subtypes are determined according to the
mode of genetic transmission, the presence or absence
of specific cutaneous and extra cutaneous findings,
and also following the recommendations of the Third
International Consensus on Diagnosis and
Classification of EB. At least 30 different epidermoly-
sis bullosa phenotypes have been described, each
resulting from mutations in molecular genes that
encode cutaneous structural proteins.2
EB is little known by professionals in general,
particularly regarding the treatment and dietary and
nutritional monitoring of the patients. Besides cuta-
neous manifestations, many EB subtypes have extra-
cutaneous clinical features that can lead to morbidity
and in some cases death.2 Therefore, its treatment
requires the involvement of a multidisciplinary team
trained in all the aspects that need care. Considering
the lack of academic research in the area, this article is
a review of the main concepts and nutritional aspects
of EB treatment, in order to provide the best health
care to the patient.
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METHOD
The following electronic databases were
searched: PubMed, SciELO, Lilacs and Medline, the
last two through the Virtual Health Library. The
search was divided into four steps:
- A survey of articles and search, in all indexes, of
the keywords “Epidermolysis Bullosa / Epidermólise
bolhosa”, combined with the logical operator “and”
“Child Nutrition” and “Adolescent Nutrition”, regis-
tered in the descriptors of health sciences. The
search limit activated was the chronological period
between 2007 and 2013. Forty-six articles were
found: 13 in PubMed, one in SciELO, 18 in Lilacs
and 15 in MedLine;
- Perusal of the titles of retrieved studies, selection
of articles that were potentially eligible for this
review and discard of those deemed unsuitable to
the objective;
- Identification of duplicated articles in the data-
bases, and elimination of the repeated ones, reach-
ing a total of 12 articles. Due to the small number
of studies, the references cited in each article sur-
veyed were also searched, yielding 6 additional
articles with themes very akin to our research,
which were also included.
- Thus we reached a total of 18 articles considered
suitable for this review. Articles about children and
adolescents with EB were analyzed regarding the
following aspects: (1) potential extra-cutaneous
manifestations that affect nutritional status, (2)
nutritional depletion and needs and (3) growth.
POTENTIAL EXTRACUTANEOUS CLINICAL
FEATURES AFFECTING THE NUTRITIONAL
STATUS OF PATIENTS WITH EB
The gravity of EB varies from mild to severe
depending on the involvement of the skin and extra-
cutaneous manifestations, and it can be localized or
generalized. Cutaneous findings may include blisters,
scars, pigmentation changes, alopecia, absent or dys-
trophic nails, and deformity of hands and feet.4 The
patient with EB, depending on its clinical type, is at
risk for developing extra-cutaneous clinical symp-
toms.2 Eyes, teeth, oral mucosa, genitourinary, gas-
trointestinal, respiratory and musculoskeletal systems
may all be involved.4
Gastrointestinal problems are common in dif-
ferent types of EB and lead to morbidity with severe
nutritional deficits, resulting in refractory anemia,
hypoalbuminemia, absorptive disorders and growth
deficit. Complications can be observed in different
parts of the gastrointestinal tract, including blistering
and stenosis of the esophagus, gastroesophageal
reflux disease, hiatal hernia, gastritis, peptic ulcer dis-
ease, protein-losing enteropathy, anal fissure, mega-
colon, inflammatory bowel disease and constipation.
Among these complications, it is worth highlighting
esophageal stenosis, which limits the consistency of
foods that can be ingested, so that at first there is dys-
phagia with solids of normal consistency, then with
soft foods and eventually liquids, and without the
appropriate intervention, it may ultimately hinder the
swallowing of saliva.2
In a retrospective study conducted in London,
including 223 children with various forms of EB treat-
ed at a national reference center, with the objective to
delineate the nature and frequency of gastrointestinal
disorders and identify the most common complica-
tions, it was observed that gastrointestinal problems
were present in 58% of patients. In patients with EBS,
constipation and gastroesophageal reflux were usual-
ly observed. In those with JEB, growth deficit and pro-
tein-losing enteropathy were the most frequently
recorded events. Constipation was common in
patients with DEB, requiring the use of laxatives and
fiber supplements. Gastroesophageal reflux affected
three quarters of children with recessive DEB; two-
thirds also had significant esophageal stenosis. In
more than half of patients with recessive DEB, inser-
tion of gastrostomy was required. Diarrhea affected a
small but significant proportion of children with
recessive DEB, with macroscopic and/or microscopic
colitis alterations in most of them.5
Constipation is one of the most common clini-
cal features in EB patients, reported in all types of the
disease and especially in recessive dystrophic EB,
which occurs in 40% to 75% of cases. Constipation
often occurs when defecation is painful due to peri-
anal blisters and fissures, leading to fecal retention
and increased constipation. Masticatory and swallow-
ing difficulties result in a low-fiber diet that combined
with reduced physical activity and the use of iron-
based supplements, often essential to the patient with
EB, can exacerbate the symptoms. Fecal impaction can
result in death due to colon perforation and peritoni-
tis. Anal stenosis, rectal prolapse, megacolon, perianal
fistulas, irritable bowel syndrome, hemorrhoids and
diverticular disease have also been described as clini-
cal manifestations in patients with EB.2
Mouth and esophageal areas may also be affect-
ed in patients with EB owing to severe blister forma-
tion in the oral mucosa, followed by scarring that
results in microstomia and ankyloglossia, which
severely restrict food ingestion.6 Teeth may be struc-
turally defective, often with poor quality enamel,
which causes weak teeth most likely to decay, gingival
diseases and extensive loss of tooth surface by ero-
sion, also affecting food intake.7
Symptoms and signs such as weight loss, no
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FIGURE 1: Cause-effect correlation of inadequate nutritional intake
in patients with severe types of EB
weight gain for more than three months, inadequate
growth, extended feeding time and vomiting may
indicate decreased ability to masticate and swallow.
Detailed assessment may show poor dentition,
painful blisters in the mouth and/or esophagus and
narrowing of the esophagus, and the interventions
include dental restoration, use of corticosteroids to
reduce dysphagia, esophageal dilation and feeding
through gastrostomy.8
Anemia is a frequent and serious complication
in severe types of EB, such as recessive DEB and junc-
tional EB. Hemoglobin levels below 10g/dl difficult
wound healing in patients with venous ulcers second-
ary to decreased tissue oxygenation. However, litera-
ture does not identify the ideal conduct to manage ane-
mia in these cases. Appropriate cutaneous care, pre-
vention and treatment of skin infections can minimize
cutaneous blood loss. Oral iron supplementation is
widely used to correct the anemia, although individual
effectiveness may vary. Moreover, gastrointestinal dis-
orders are causes for non-adherence. Transfusions
should be considered in cases in which hemoglobin
levels are consistently below 8g/dl and in sympto-
matic patients failing to respond to other treatments.9
NUTRITIONAL COMPROMISE AND REQUIRE-
MENTS IN EB
The nutritional impairment in patients with EB
is directly related to the severity of associated prob-
lems, i.e., the more severe the EB type, the more exten-
sive the nutritional impairment. Children and adoles-
cents with junctional or recessive dystrophic EB, as
well as Dowling-Meara, a subtype of EB simplex,
have a significant risk of nutritional deficits.10,11 This is
due to numerous complications such as blisters and
oral ulcerations, compromised esophageal mobility,
esophageal stenosis, dysphagia, dental problems,
digestive and absorptive disorders, anal erosions and
fissures and rectal constriction. These events result in
chronic constipation, blood and protein loss through
the blisters, hypermetabolism secondary to the
increase in thermogenesis and protein turnover, espe-
cially in the presence of infection. These issues have
the greatest significance in children and adolescents
due to their immense nutritional requirements to
achieve proper growth.12 The interactions between
these and other factors are a challenge to the establish-
ment of the best conduct and it becomes very difficult
to determine which interventions are priorities
(Figure 1).
Malnutrition in EB patients, being the result of
a combination of decreased food intake and increased
nutrient demand, leads to failure to thrive , delayed
puberty, anemia and a cascade of clinical and biologi-
cal events that, together, culminate with the interrup-
tion or retardation of wound healing.9 Nutritional
depletion and protein-energy malnutrition can result
in alteration of immunocompetence, and secondary
bacterial infections have been reported in EB patients.6
The nutritional needs of children and adoles-
cents with minimal blisters and little or no gastroin-
testinal involvement are unlikely to be higher than
those of their healthy peers with matching age and
sex. In severe forms of EB, however, it is difficult to
quantify the nutritional needs due to a number of fac-
tors, such as: 1- the multisystemic, inflammatory and
infectious nature of the disease; 2-variable nutritional
requirements reflecting the age, extent of blisters,
presence of infection, need for catch-up growth,
among others; 3-difficulties associated with desirable
weight gain estimates, since height is also affected by
chronic inflammation, pain, osteoporosis and articular
contractures and 4-difficulty in conducting clinical tri-
als due to the limited number of patients.10
Some authors compare the energy require-
ments of children with EB to those of burned children,
because of their increased metabolic levels and energy
needs, which correspond to the affected body surface
percentage. The energy requirement for burned chil-
dren takes into account an equation for determining
the affected body surface area and also the demands
for growth maintenance and this equation can be
adapted to estimate the needs of EB patients.6 A pro-
posal, based on the equation developed for burned





















Adapted from: Haynes L, 2010.10
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ments for children and adolescents suffering from EB,
who are at nutritional risk, particularly those with
junctional and dystrophic types. This equation consid-
ers a number of factors: weight, kilocalories per kilo-
gram of body weight according to the current age at
the 25th percentile of standardized growth curves, per-
centage of body area affected by blisters, presence of
infection and need for catch-up growth (Figure 2).
This equation, despite having been released to the sci-
entific community in 1995, is still used and cited in
recent articles.8,10
However, this equation is criticized for being
subjective. A more simplified method of estimating
energy requirements for children and adolescents
with EB is proposed, and it consists in providing 100%
to 150% of the Estimated Energy Requirement (EER),
which is part of the Dietary Reference Intake (DRI).
And if growth is not satisfactory, based on its regular
assessments, a gradual increase in energy supply
should be initiated.10 For children and adolescents
who do not have nutritional risks, a likely reduction in
energy consumption is suggested, to avoid the poten-
tial hazard of overweight. The latter is secondary to
feet blisters that limit the activity and the ability to
exercise, which decreases energy requirements and if
energy consumption is not matched to its needs,
weight gain and increase in pressure on the feet will
occur. Therefore, energy consumption must be adjust-
ed so that patients can reach or maintain the adequate
weight for their height.8
Because of the great protein loss through blis-
ters, the constant need for skin synthesis and recur-
rent infections, the protein needs of patients with EB
are greater than those of their healthy peers of match-
ing gender and age. Despite the lack of information on
the quantification of cutaneous protein loss in patients
with EB, it is supposed to be quite significant, which
reduces the possibility of maintaining a positive nitro-
gen balance.6 The protein requirement is calculated
using the offer of 115-200% of the estimated average
requirement according to the Recommended Dietary
Allowances (RDA), a component of the DRI, for the
respective chronological age.13
Regarding micronutrients, there are no specific
guidelines that advise on their intake for patients with
EB, making the conduct, in these case, empirical.10
Micronutrient deficiencies in these patients result
from losses through the skin, chronic inflammation
and inadequate intake. A study including 73 patients
with various types of EB, aimed to evaluate plasmatic
or erythrocyte levels of ten nutrients (vitamins A, C,
B6 and B12, folate, thiamin, riboflavin, copper, zinc
and iron), found low plasma levels of zinc and iron (in
junctional and recessive dystrophic EB), vitamin C
(mainly EBS), vitamin A (junctional and recessive dys-
trophic EB), vitamin B12 (mainly EBS) and vitamin B6
(especially recessive dystrophic EB). With the excep-
tion of low iron and zinc plasma levels in JEB and
recessive dystrophic EB, only a minority of patients in
any of the EB subsets had low levels of other nutri-
ents, and an apparent correlation with malabsorption
was possible only with selected nutrients. Normal lev-
els of thiamine, riboflavin, folate and copper were
found in all examined patients, regardless of EB type
and the extent of cutaneous and extra-cutaneous man-
ifestations. The authors concluded that, based on nor-
mal plasma levels of most nutrients, excessive use of
vitamin supplements is unnecessary for the majority
of patients with EB, especially for those with EBS and
dominant DEB, in which adequate oral intake is still
possible. However, considering the safe levels of daily
vitamins intake, it may be a prudent practice for
patients with more severe forms of JEB and recessive
DEB, since they have a more accentuated gastroin-
testinal involvement.14
If there are doubts adequacy intake of vitamin a
specialized nutritional formula or an age-appropriat-
ed multivitamin should be recommended based on
the dietary intake assessment, provided intakes does
not exceed the Tolerable Upper Intake Level (UL),
which is one component of DRI. Children and adoles-
cents, who consume a significant amount of special-
ized nutritional formulas, acquire vitamin supplies
through  them. However, if the regular intake of vita-
mins is less than 150% of the consumption references,
then a multivitamin should be prescribed.10
Despite severe lesions in grave forms of EB hav-
ing similarities with thermal burns, an extrapolation
of the latter’s nutrient requirements should not be
automatically applied to the former, because mega-
doses of some nutrients are supposed to be used only
for a short timeframe, whereas EB patients constantly
present skin lesions. In the absence of specific data
Energy requirement calculation
Weight(kg) x (kcal/Kg age corresponding to the height on•
the 25th percentile) x [1 + (sum of 3 additional factors)]
Additional factors•












Adapted from: Haynes L, 2007.12
FIGURE 2: Energy requirement estimate for patients with EB
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addressing patients with EB, the development of a
dietary plan regarding nutritional requirements
includes: 1-Evaluation of factors that interfere with
food intake and nutrient absorption; 2-Biochemical
assessment, although interpretation of results may be
difficult due to inflammatory response effects, which
alter micronutrient concentration; 3- Estimate of nutri-
tional intake in children and adolescents with severe
forms of EB, compared with the needs of healthy indi-
viduals of same sex and age, matched height, with the
addition of factors that may increase energy and pro-
tein needs.10
Regarding the causes of constipation, blisters
and fissures in the anal region of patients with dys-
trophic and junctional EB, favor the accumulation of
feces. This process stems from the fear of pain during
bowel movement, moreover, other factors contribute
to the problem, such as low-fiber diet, diminished
fluid intake, fluid loss through skin lesions and limit-
ed physical activity.8 Although low consumption of
fibers contributes to constipation in these patients, for
many children an increase in the amount of fibers
through conventional foods may not be appropriate
or successful. These are the cases of patients with oral
lesions or esophageal stenosis that difficult swallow-
ing; those who require greater density of nutrients
than is available in some kinds of foods; children
younger than five years, who are unlikely to consume
certain types of food in quantities enough to alleviate
constipation and those with perianal lesions present-
ing extremely painful defecations. In such instances,
the use of specialized nutritional formulas containing
high percentage of insoluble fibers have been benefi-
cial to alleviate chronic constipation.13
Feeding via gastrostomy may be necessary to
improve the nutritional status of patients with more
severe forms of EB.9 A retrospective study performed
at the French Reference Center for Genetic Cutaneous
Diseases (MAGEC), evaluated long-term enteral feed-
ing via gastrostomy including information about
energy and protein requirements, enteral feeding tol-
erability, growth and pubertal development in young
patients with recessive DEB (REBD). It was demon-
strated that the amount of calories and proteins neces-
sary to achieve catch-up growth with enteral feeding
via gastrostomy should be higher than the dietary
intake references for the healthy population. The aver-
age protein intake via gastrostomy was equivalent to
180% of the dietary consumption references and the
energy supply was 129%. These values  were expected
in view of the large protein loss through the skin and
its increased requirement due to the chronic inflam-
mation observed in these patients. The authors con-
cluded that feeding via gastrostomy should be initiat-
ed before the onset of malnutrition in order to
improve growth recovery, and before the age of ten to
allow pubertal development, which has a positive
psychological impact.15
The goals of nutritional interventions in chil-
dren and adolescents with EB are to ease the stress
caused by feeding time, minimize nutritional deficien-
cies, improve bowel function, enhance the immuno-
logical status, optimize wound healing, build-up nor-
mal body composition and promote proper growth, as
well as pubertal and sexual developments.
Considering the grave prognosis of some EB types,
these goals should be modified according to the
patient’s situation, with emphasis on the quality of
life. Despite nutritional intervention, few children
with other severe EB subtypes will experience signifi-
cant improvement in wound healing rates, which is a
disappointing, albeit not surprising fact, considering
the great involvement of the skin. However the poten-
tial effect of adequate nutritional intake is more com-
prehensive.10
Even if nutritional intervention is not associat-
ed with the prevention of new blisters, improvements
in immunocompetence, visceral proteins and normal-
ization of biochemical levels and, consequently, accel-
eration of wound healing and prevention of second-
ary bacterial infection have been recorded.6 The earli-
er the age of nutritional management start, the greater
the likelihood of nutritional deficiency recovery.
Although early assessment and nutritional interven-
tion enable substantial improvements in nutritional
status and growth, improve several quality of life
aspects and reduce morbidity and mortality, in many
cases, it is impossible to attain nutritional needs and
promote satisfactory growth solely through food
intake. In multisystemic conditions, such as EB, the
success of nutritional intervention invariably depends
on the satisfactory management of a number of asso-
ciated factors.
GROWTH OF CHILDREN AND ADOLESCENTS
WITH EB
Various degrees of growth retardation com-
monly occur in the most severely affected patients
with EB, the majority has Hallopeau-Siemens reces-
sive dystrophic EB and junctional Herlitz, with many
children failing to reach the 5th percentile of
weight/height curves.2 Other authors confirmed this
finding and reported that the majority of children
with severe types of EB have abnormal development.16
In a study with 80 patients with different types
of EB, aimed to analyze nutritional risks and growth
parameters, 22% of the eighteen children with EB sim-
plex were at risk for malnutrition, while 57% of those
with junctional EB and 77% of those with dystrophic
EB had nutritional risks. Height impairment, usually
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attributed to chronic protein-energy malnutrition, was
observed in 11% of children with EB simplex, 29%
with junctional EB and 60% with dystrophic EB.
Eighty-six percent of adults with dystrophic EB were
underweight, showing that nutritional risks extend
into adulthood. Among adult patients with EB sim-
plex, 62% were overweight; probably due to reduced
physical activity secondary to feet blisters.8 The study
concluded that the nutritional status of patients with
EB showed malnutrition with height impairment,
especially in patients with junctional EB and recessive
dystrophic EB.
Regarding overweight in patients with EBS,
another author confirms the findings of the study
aforementioned, citing that in EB simplex, excess
weight is often observed in children and adolescents
because lesions are mainly confined to the feet and so
patients have a predominantly sedentary lifestyle and
moreover, factors that in early childhood were respon-
sible for poor oral intake of food, decrease subse-
quently.10
A survey was conducted with English patients
and their closest peers unaffected by the disease in
order to compare the birthweight of children affected
by recessive EBD and a control group. It was observed
that children with REBD had significantly lower birth-
weight, demonstrating that impaired growth begins
in utero.17 Another study that did not specify EB sub-
types confronted these findings affirming that, gener-
ally, children with EB are born at term with appropri-
ate weight and height, however, after birth the disease
manifestations difficult food consumption whilst
nutritional needs increase.8
In the first year of life, a satisfactory growth rate
can be achieved in patients with EB as result of the use
of fortified infant formulas, late introduction of com-
plementary feeding and nutrient concentration meth-
ods, although these rates are rarely sustained in
severely affected children. The critical point begins
during teething and at the time of the first childhood
diseases, and later, when the child enters school and
has less feeding periods during the day.13 A retrospec-
tive study conducted in France, including young
patients with recessive DEB fed via gastrostomy,
found that despite nutritional monitoring, growth
retardation occurs early in the course of the disease, at
an average of 3-years for weight and 4.9 years for
height.15
Special attention should be given to puberty,
since this period has the highest growth rate and
therefore increased nutritional demands. A child with
EB presenting very low weight-to-height ratio may
have less mobility and tend to rely on a wheelchair. It
is important to maintain a balance between mobility,
growth and nutritional status, because these are inter-
related and interdependent aspects. Extremely low
weight, wheelchair dependence and low bone mass
are frequent in children with JEB and DREB, leading
to higher probabilities of bone pain, fractures and
increased immobility. Nevertheless, malnourished
children may not reach puberty and benefit from the
hormonal protective effects on bone health.10
Children and adolescents with more severe
types of EB have significant changes in body compo-
sition, with loss of fat and muscle mass. Chronic infec-
tions are one of the causes of malnutrition and growth
retardation and it is likely that the inhibitory effects of
proinflammatory cytokines on growth, also observed
in childhood chronic inflammatory conditions such as
Crohn’s disease and juvenile arthritis, can be seen in
patients with severe EB, since the cytokine-mediated
cascade of events leads to catabolism.10,16
Patients at the Great Ormond Street Hospital in
London, with serious types of EB and growth retarda-
tion during adolescence, presented hypogonadism
with low serum concentration levels of luteinizing
and follicle-stimulating hormones, which are respon-
sible for stimulating the activity of ovaries and testes.
The authors also observed reduced concentrations of
insulin-like growth factor-1 (IGF-1) and IGF-binding
protein-3 (IGFBP3), which are proteins produced and
secreted by the pituitary gland to induce the increase
of cells volume and numbers, enabling tissue, organ
and consequently, body growth. These same findings
are observed in patients with chronic diseases.
Although the hormone system has not been fully eval-
uated in patients with EB, malnutrition plays a major
role in their growth impairment.16
The determination of the optimal growth rate
for children with severe EB is complex and should
always be considered in the context of the individual
patient and the severity of the disease. Since complica-
tions of EB vary in number and intensity over time, it
is very difficult to judge if growth and nutritional sta-
tus are good. Monitoring of weight gain and growth
rates are well-recognized instruments to assess the
adequate development of healthy and sick children
and adolescents, nevertheless, the correlation to chil-
dren with EB have limited value.10
Considering the growth and development
impairment of children and adolescents with EB, it is
worth noting that, there is no cure for EB and that
hope for those affected lays on ongoing studies in
gene therapy. Meanwhile, treatments of clinical symp-
toms, as well as multi-professional assistance, are
effective strategies just to control the disease.18
FINAL CONSIDERATIONS
Despite Epidermolysis Bullosa being a disease
with cutaneous manifestations, depending on its type,
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it will present extra-cutaneous features that may affect
the growth and nutritional status of children and ado-
lescents. Among those, we should highlight anemia,
constipation and other features with potential to affect
food intake, oral cavity blisters, dental problems,
ankyloglossia, microstomia, digestive and absorptive
problems and esophageal stenosis. On the other hand,
children and adolescents with EB have increased ener-
gy and nutrient needs due to the growing phases,
added to constant blister healing, cutaneous losses
and inflammatory and infectious processes that may
occur in the lesions. Therefore, the association of inad-
equate food intake and increased nutrient require-
ments leads to impaired nutritional status and conse-
quently, overall poor health. ❑
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